BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | +38.9% | 1,000 | -80.2% | 0.01% | 0.0% |
| Q2 2023 | $36 | -55.0% | 5,056 | +180.9% | 0.01% | -37.5% |
| Q1 2023 | $80 | +2.6% | 1,800 | 0.0% | 0.01% | +14.3% |
| Q4 2022 | $78 | -99.9% | 1,800 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $118,000 | -53.2% | 1,800 | -64.0% | 0.01% | -55.6% |
| Q2 2022 | $252,000 | +106.6% | 5,000 | -46.5% | 0.02% | +200.0% |
| Q1 2022 | $122,000 | -43.0% | 9,340 | +367.0% | 0.01% | -33.3% |
| Q4 2021 | $214,000 | -30.5% | 2,000 | -33.3% | 0.01% | -35.7% |
| Q3 2021 | $308,000 | -3.8% | 3,000 | -17.6% | 0.01% | -6.7% |
| Q2 2021 | $320,000 | -9.3% | 3,640 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $353,000 | +275.5% | 3,640 | -67.5% | 0.02% | +325.0% |
| Q4 2020 | $94,000 | +25.3% | 11,200 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $75,000 | +7.1% | 11,200 | +1144.4% | 0.01% | 0.0% |
| Q2 2020 | $70,000 | -36.9% | 900 | -52.6% | 0.01% | -16.7% |
| Q1 2020 | $111,000 | -14.0% | 1,900 | -34.5% | 0.01% | -25.0% |
| Q4 2019 | $129,000 | -74.4% | 2,900 | -88.3% | 0.01% | -82.6% |
| Q3 2019 | $503,000 | +136.2% | 24,700 | +434.6% | 0.05% | +130.0% |
| Q2 2019 | $213,000 | -32.2% | 4,620 | -46.9% | 0.02% | -37.5% |
| Q1 2019 | $314,000 | +54.7% | 8,700 | +70.6% | 0.03% | +60.0% |
| Q4 2018 | $203,000 | +84.5% | 5,100 | +240.0% | 0.02% | +150.0% |
| Q3 2018 | $110,000 | -3.5% | 1,500 | -16.7% | 0.01% | -11.1% |
| Q2 2018 | $114,000 | +128.0% | 1,800 | -75.3% | 0.01% | +80.0% |
| Q1 2018 | $50,000 | +138.1% | 7,300 | +78.0% | 0.01% | +400.0% |
| Q4 2017 | $21,000 | +110.0% | 4,100 | +925.0% | 0.00% | – |
| Q3 2017 | $10,000 | -60.0% | 400 | -84.0% | 0.00% | -100.0% |
| Q2 2017 | $25,000 | -95.7% | 2,500 | -95.3% | 0.00% | -95.8% |
| Q1 2017 | $578,000 | +4346.2% | 53,424 | +320.7% | 0.02% | – |
| Q4 2016 | $13,000 | -71.7% | 12,700 | +29.6% | 0.00% | -100.0% |
| Q3 2016 | $46,000 | – | 9,800 | +9700.0% | 0.00% | – |
| Q1 2016 | $0 | – | 100 | -50.0% | 0.00% | – |
| Q4 2015 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |